Buspirone Is Effective On Central Apneas In Patients With Systolic Heart Failure

Chiara Borrelli,Gianluca Mirizzi,Claudio Passino,Francesca Bramanti,Giovanni Iudice,Eleonora Benelli,Assunta Agazio, Francesco Grotti,Michele Emdin,Alberto Giannoni

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 4|浏览15

暂无评分

摘要

The current therapeutic approach for central apneas (CA) in heart failure (HF) with non-invasive mechanical ventilation -that targets “sleep apneas”- has a negative prognostic impact and does not affect CA pathophysiological triggers or daytime CA. We hypothesized that buspirone, a 5HT1a

查看译文

关键词

systolic heart failure,heart failure

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要